Since the onset of the COVID-19 pandemic, consumers and producers have learned to adapt to many new and unforeseen challenges and hardships. For biotech companies in 2022, navigating the shortages and delays in the global supply chain is one such challenge that looks set to continue through the rest of the year. Data Evolution has outlined three tips to help biotech companies mitigate these issues until the global supply chain fully recovers.

Companies across all industries are dealing with supply chain issues and shortages in 2022. From extended delivery times to product unavailability continuing for weeks and months, companies have had to learn to be flexible and adapt to the difficulties presented by global supply chain issues.